Patents by Inventor Edward Flanagan
Edward Flanagan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230009153Abstract: The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl and pyrrolo[2,3-d]pyridinyl acrylamides and analogues thereof. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.Type: ApplicationFiled: August 4, 2021Publication date: January 12, 2023Applicant: Pfizer Inc.Inventors: Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Ye Che, Jotham Wadsworth Coe, Mark Edward Flanagan, Adam Matthew Gilbert, Matthew Merrill Hayward, Jonathan David Langille, Justin Ian Montgomery, Jean-Baptiste Telliez, Rayomand Jal Unwalla, John I. Trujillo
-
Patent number: 11360788Abstract: A configuration control transfer (“CCT”) system controls the transferring of control of configuration information of a device from a current configuration source to a target configuration source. A CCT server of the CCT system may send a request for the configuration information of the device where the configuration information of the device currently under control of the at least one first configuration source. The CCT server may also receive the requested configuration information, determine whether the second configuration source is able to support the configuration information of the first configuration source, and based at least on a determination that the second configuration source is able to support the configuration information, request that the device transfer control of the configuration information from the first configuration source to the second configuration source to unenroll the device with the first configuration source and enroll the device with the second configuration source.Type: GrantFiled: March 31, 2020Date of Patent: June 14, 2022Assignee: Microsoft Technology Licensing, LLCInventors: Tanvir Ahmed, Peter J. Kaufman, Shayak Lahiri, John Chadwell Spaith, Janani Vasudevan, Dennis Edward Flanagan
-
Patent number: 11111242Abstract: The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl and pyrrolo[2,3-d]pyridinyl acrylam ides and analogues thereof, having the structure: or a pharmaceutically acceptable salt thereof, as set forth in the Description. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.Type: GrantFiled: March 1, 2017Date of Patent: September 7, 2021Assignee: Pfizer Inc.Inventors: Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Ye Che, Jotham Wadsworth Coe, Mark Edward Flanagan, Adam Matthew Gilbert, Matthew Merrill Hayward, Jonathan David Langille, Justin Ian Montgomery, Jean-Baptiste Telliez, Rayomand Jal Unwalla, John I. Trujillo
-
Publication number: 20200257542Abstract: A configuration control transfer (“CCT”) system controls the transferring of control of configuration information of a device from a current configuration source to a target configuration source. A CCT server of the CCT system may send a request for the configuration information of the device where the configuration information of the device currently under control of the at least one first configuration source. The CCT server may also receive the requested configuration information, determine whether the second configuration source is able to support the configuration information of the first configuration source, and based at least on a determination that the second configuration source is able to support the configuration information, request that the device transfer control of the configuration information from the first configuration source to the second configuration source to unenroll the device with the first configuration source and enroll the device with the second configuration source.Type: ApplicationFiled: March 31, 2020Publication date: August 13, 2020Applicant: Microsoft Technology Licensing, LLCInventors: Tanvir Ahmed, Peter J. Kaufman, Shayak Lahiri, John Chadwell Spaith, Janani Vasudevan, Dennis Edward Flanagan
-
Patent number: 10732150Abstract: A sensor device includes: a probe body having a first end and a second end, the probe body defining a probe cavity within the probe body; a sensor located at the first end of the probe body, the sensor having a sensor surface in sensory communication with the probe cavity defined within the probe body; a permanent magnet located adjacent the second end of the probe body and at least partially circumscribing the probe cavity defined within the probe body; an isolating boundary portion located between the permanent magnet and a surface of the object of interest and having a passage formed therethrough, the passage in communication with the probe cavity defined within the probe body.Type: GrantFiled: September 7, 2017Date of Patent: August 4, 2020Inventor: Edward Flanagan
-
Patent number: 10703756Abstract: The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl, and pyrrolo[2,3-b]pyridinyl acrylamides, epoxides, and analogues thereof. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.Type: GrantFiled: April 19, 2016Date of Patent: July 7, 2020Assignee: Pfizer Inc.Inventors: Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Ye Che, Mark Edward Flanagan, Adam Matthew Gilbert, Matthew Merrill Hayward, Jean-Baptiste Telliez, Rayomand Jal Unwalla, John I. Trujillo, Sidney Xi Liang
-
Patent number: 10628174Abstract: A configuration control transfer (“CCT”) system controls the transferring of control of configuration information of a device from a current configuration source to a target configuration source. A CCT server of the CCT system may send to the device a message requesting the configuration information of the device. In response, a CCT client of the CCT system collects the configuration information of the device and sends the collected configuration information to the CCT server. If the second configuration source can support the configuration information of the current configuration source, the CCT server requests that the device transfer control of the configuration information from the current configuration source to the target configuration source. The CCT client then transfers control of the configuration information to the target configuration source as the new current configuration source and un-enrolls the device from the former current configuration source.Type: GrantFiled: February 17, 2016Date of Patent: April 21, 2020Assignee: Microsoft Technology Licensing, LLCInventors: Tanvir Ahmed, Peter J. Kaufman, Shayak Lahiri, John Chadwell Spaith, Janani Vasudevan, Dennis Edward Flanagan
-
Publication number: 20190072525Abstract: A sensor device includes: a probe body having a first end and a second end, the probe body defining a probe cavity within the probe body; a sensor located at the first end of the probe body, the sensor having a sensor surface in sensory communication with the probe cavity defined within the probe body; a permanent magnet located adjacent the second end of the probe body and at least partially circumscribing the probe cavity defined within the probe body; an isolating boundary portion located between the permanent magnet and a surface of the object of interest and having a passage formed therethrough, the passage in communication with the probe cavity defined within the probe body.Type: ApplicationFiled: September 7, 2017Publication date: March 7, 2019Inventor: Edward Flanagan
-
Patent number: 10216297Abstract: A flexible, scalable hardware input device for interacting with a variety of devices ranging from a phone, to a media playback device to a steering wheel or a tablet PC is provided. The input device includes a set of mechanical input controls, each mapping to one or more independent functions and a set of touch sensitive input control areas (e.g., capacitive), where each touch sensitive input control area receives touch input independently. In addition, one or more of the touch sensitive input control areas interchangeably overlay one or more of the mechanical input controls, whereby interaction with the touch sensitive input control areas is processed together to determine a corresponding function for controlling the application, service or computing device.Type: GrantFiled: September 24, 2014Date of Patent: February 26, 2019Assignee: Microsoft Technology Licensing, LLCInventors: Brett Allen Bentsen, Dennis Edward Flanagan, Gregory Sean Cox, Thamer A. Abanami
-
Publication number: 20190002466Abstract: The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl, and pyrrolo[2,3-b]pyridinyl acrylamides, epoxides, and analogues thereof. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.Type: ApplicationFiled: April 19, 2016Publication date: January 3, 2019Applicant: Pfizer Inc.Inventors: Atli THORARENSEN, Matthew Frank BROWN, Agustin CASIMIRO-GARCIA, Ye CHE, Mark Edward FLANAGAN, Adam Matthew GILBERT, Matthew Merrill HAYWARD, Jean-Baptiste TELLIEZ, Rayomand Jal UNWALLA, John I. TRUJILLO, Sidney Xi LIANG
-
Publication number: 20170247372Abstract: The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl and pyrrolo[2,3-d]pyridinyl acrylamides and analogues thereof. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.Type: ApplicationFiled: March 1, 2017Publication date: August 31, 2017Applicant: Pfizer Inc.Inventors: Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Ye Che, Jotham Wadsworth Coe, Mark Edward Flanagan, Adam Matthew Gilbert, Matthew Merrill Hayward, Jonathan David Langille, Justin Ian Montgomery, Jean-Baptiste Telliez, Rayomand Jal Unwalla, John I. Trujillo
-
Publication number: 20170235583Abstract: A configuration control transfer (“CCT”) system controls the transferring of control of configuration information of a device from a current configuration source to a target configuration source. A CCT server of the CCT system may send to the device a message requesting the configuration information of the device. In response, a CCT client of the CCT system collects the configuration information of the device and sends the collected configuration information to the CCT server. If the second configuration source can support the configuration information of the current configuration source, the CCT server requests that the device transfer control of the configuration information from the current configuration source to the target configuration source. The CCT client then transfers control of the configuration information to the target configuration source as the new current configuration source and un-enrolls the device from the former current configuration source.Type: ApplicationFiled: February 17, 2016Publication date: August 17, 2017Inventors: Tanvir Ahmed, Peter J. Kaufman, Shayak Lahiri, John Chadwell Spaith, Janani Vasudevan, Dennis Edward Flanagan
-
Patent number: 9617258Abstract: The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl and pyrrolo[2,3-d]pyridinyl acrylamides and analogues thereof, having the structure: or a pharmaceutically acceptable salt or solvate thereof, or an enantiomer or diastereomer thereof, as set forth in the Description. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.Type: GrantFiled: December 3, 2014Date of Patent: April 11, 2017Assignee: Pfizer Inc.Inventors: Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Ye Che, Jotham Wadsworth Coe, Mark Edward Flanagan, Adam Matthew Gilbert, Matthew Merrill Hayward, Jonathan David Langille, Justin Ian Montgomery, Jean-Baptiste Telliez, Rayomand Jal Unwalla, John I. Trujillo
-
Patent number: 9549929Abstract: Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.Type: GrantFiled: May 18, 2015Date of Patent: January 24, 2017Assignee: Pfizer Inc.Inventors: Matthew Frank Brown, Ashley Edward Fenwick, Mark Edward Flanagan, Andrea Gonzales, Timothy Allan Johnson, Neelu Kaila, Mark J. Mitton-Fry, Joseph Walter Strohbach, Ruth E. TenBrink, John David Trzupek, Rayomand Jal Unwalla, Michael L. Vazquez, Mihir D. Parikh
-
Patent number: 9545405Abstract: Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.Type: GrantFiled: April 21, 2015Date of Patent: January 17, 2017Assignee: Pfizer Inc.Inventors: Matthew Frank Brown, Ashley Edward Fenwick, Mark Edward Flanagan, Andrea Gonzales, Timothy Allan Johnson, Neelu Kaila, Mark J. Mitton-Fry, Joseph Walter Strohbach, Ruth E. TenBrink, John David Trzupek, Rayomand Jal Unwalla, Michael L. Vazquez, Mihir D. Parikh
-
Publication number: 20150246048Abstract: Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.Type: ApplicationFiled: May 18, 2015Publication date: September 3, 2015Inventors: Matthew Frank Brown, Ashley Edward Fenwick, Mark Edward Flanagan, Andrea Gonzales, Timothy Allan Johnson, Neelu Kaila, Mark J. Mitton-Fry, Joseph Walter Strohbach, Ruth E. TenBrink, John David Trzupek, Rayomand Jal Unwalla, Michael L. Vazquez, Mihir D. Parikh
-
Publication number: 20150225408Abstract: Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.Type: ApplicationFiled: April 21, 2015Publication date: August 13, 2015Inventors: Matthew Frank Brown, Ashley Edward Fenwick, Mark Edward Flanagan, Andrea Gonzales, Timothy Allan Johnson, Neelu Kaila, Mark J. Mitton-Fry, Joseph Walter Strohbach, Ruth E. TenBrink, John David Trzupek, Rayomand Jal Unwalla, Michael L. Vazquez, Mihir D. Parikh
-
Publication number: 20150158864Abstract: The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl and pyrrolo[2,3-d]pyridinyl acrylamides and analogues thereof. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.Type: ApplicationFiled: December 3, 2014Publication date: June 11, 2015Inventors: Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Ye Che, Jotham Wadsworth Coe, Mark Edward Flanagan, Adam Matthew Gilbert, Matthew Merrill Hayward, Jonathan David Langille, Justin Ian Montgomery, Jean-Baptiste Telliez, Rayomand Jal Unwalla
-
Patent number: 9035074Abstract: Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.Type: GrantFiled: February 19, 2014Date of Patent: May 19, 2015Assignee: Pfizer Inc.Inventors: Matthew Frank Brown, Ashley Edward Fenwick, Mark Edward Flanagan, Andrea Gonzales, Timothy Allan Johnson, Neelu Kaila, Mark J. Mitton-Fry, Joseph Walter Strohbach, Ruth E. TenBrink, John David Trzupek, Rayomand Jal Unwalla, Michael L. Vazquez, Mihir D. Parikh
-
Publication number: 20150009148Abstract: A flexible, scalable hardware input device for interacting with a variety of devices ranging from a phone, to a media playback device to a steering wheel or a tablet PC is provided. The input device includes a set of mechanical input controls, each mapping to one or more independent functions and a set of touch sensitive input control areas (e.g., capacitive), where each touch sensitive input control area receives touch input independently. In addition, one or more of the touch sensitive input control areas interchangeably overlay one or more of the mechanical input controls, whereby interaction with the touch sensitive input control areas is processed together to determine a corresponding function for controlling the application, service or computing device.Type: ApplicationFiled: September 24, 2014Publication date: January 8, 2015Inventors: Brett Allen Bentsen, Dennis Edward Flanagan, Gregory Sean Cox, Thamer A. Abanami